HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With CBD Poised To Become A Novel Food In Europe, Industry Must Think Ahead To Gain Advantage

Executive Summary

Europe's dynamic CBD market could soon see tighter regulation, after the European Commission (EC) last month added the ingredient to its Novel Food Catalogue. Regulatory expert Janet Worrell argues that the time is now for CBD industry players to act to get ahead of this potentially transformative development. 

You may also be interested in...



EU CBD Market Under Threat With Narcotic Classification Favored

Leaning towards classifying CBD as a narcotic, the European Commission could dash hopes of a regulated EU market for dietary supplements containing the cannabinoid. 

Unauthorized CBD Sold In Europe Most Likely To Originate From UK

The UK was the most likely source of unauthorized CBD food products sold in the EU in the first half of 2020, an analysis by HBW Insight reveals. Ireland and Spain are leading the way in cracking down on such products and informing neighboring countries of the risks posed.

US Firm Mile High Files CBD Novel Food Applications In EU

Colorado's Mile High Labs has filed novel food applications with both EFSA and the UK's FSA to ensure it can keep legally supplying its hemp-derived CBD to European customers.

Related Content

Topics

UsernamePublicRestriction

Register

LL1135307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel